Metri Bio Expands Its Voice Across Women’s Health and Biotechnology
The Metri team at the Women’s Health Summit Throughout the second quarter of 2026, Metri Bio contributed to conversations shaping the future of biotechnology, women’s health, and endometriosis research. CEO and co-founder Ashley Abel represented the company at major industry gatherings, including the Forbes 30 Under 30 Summit, the Yale Innovation Summit, MIT’s Science and […]
Dr. Michael Rogers Joins Metri Bio’s Scientific Advisory Board
Metri Bio has welcomed Michael S. Rogers, PhD, to its Scientific Advisory Board. Dr. Rogers is an Associate Professor of Surgery at Harvard Medical School and a principal investigator in the Vascular Biology Program at Boston Children’s Hospital, where his laboratory develops new approaches to understand and treat endometriosis-associated pain. Dr. Rogers and his collaborators […]
Metri Bio Featured in EndoRISE’s “1 in 10” Endometriosis Story
The Jackson Laboratory’s feature on EndoRISE highlights Connecticut’s first-in-the-nation, state-supported effort to accelerate endometriosis research, care, education, and awareness. Metri Bio co-founder Ashley Abel appears in the story alongside researchers, patients, advocates, and public leaders working to create a more coordinated model for progress, emphasizing the need for a quantum leap in endometriosis research rather […]
Pillar VC Shares Why It Invested in Metri Bio
In “Immovable Object, Meet Unstoppable Force,” Pillar VC’s Thomas de Vlaam reflects on the scientific complexity of endometriosis, the scale of its unmet need, and the convergence of people and technology behind Metri Bio. The article traces Ashley Abel’s path from Yale research to building a company focused on human-relevant models and the discovery of […]
HealthyWomen Profiles Ashley Abel’s Mission to End Endometriosis
HealthyWomen spoke with Metri Bio CEO and co-founder Ashley Abel about the scientific insight that inspired the company, the limitations of existing endometriosis models, and Metri’s work to build patient-derived human tissue models for discovering targeted therapies. The conversation also explores why endometriosis should be understood as a full-body disease, not only a fertility condition, […]